Thing is, if the Germany thing was an under stated but known risk, KM should not have hired a sales team for a year and then fired them.
As far as the HealthNet settlement, hopefully it helps with Hikma suit because it has definitely not caused BCBS to reinstate brand V to their formulary.
Nsleven..."Germany was an understated risk"...I don't fault KM for failing to get reimbursed by Germany, but I do fault him for hiring reps prior to German approval for Vascepa reimbursements...I also fault him for not being more open about the Healthnet agreement and the deal that Amarin has with Mochida...especially his plans for MND-2119.